Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). ReFacto AF is appropriate for use in adults and children of all ages, including newborns. ReFacto AF does not contain von Willebrand factor, and hence is not indicated in von Willebrand's disease.
Pfizer has taken back the Nordic territory rights to reclaim to the blood clotting factors ReFacto and BeneFIX from Swedish...